<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04909008</url>
  </required_header>
  <id_info>
    <org_study_id>20-011347</org_study_id>
    <nct_id>NCT04909008</nct_id>
  </id_info>
  <brief_title>Exercise Training to Improve Cardiopulmonary Hemodynamics in Heart Failure Patients</brief_title>
  <official_title>Exercise Training to Improve Pulmonary Haemodynamic and Right Ventricular Function in Heart Failure Patients With Pulmonary Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Florida Heart Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study is being done to find out if exercise therapy can help improve the heart&#xD;
      function, overall health, and quality of life of patients with pulmonary hypertension caused&#xD;
      by heart failure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this research is to see if taking part in structured exercise training will&#xD;
      improve the ability to exercise, the function of the heart, and the function of the blood&#xD;
      vessels that supply the lungs in patients with heart failure and pulmonary hypertension.&#xD;
      After enrollment all patients will complete exercise testing. Patients will be randomized to&#xD;
      either 10 weeks of exercise training (3 times per week) or will continue standard medical&#xD;
      care. All patients will undergo detailed exercise testing before and after the intervention.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2021</start_date>
  <completion_date type="Anticipated">May 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized control trial</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal oxygen uptake (VO2max) measured in mL/kg/min</measure>
    <time_frame>10 weeks</time_frame>
    <description>VO2max is the maximal measured oxygen uptake during a symptom limited exercise test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean pulmonary arterial pressure (mPAP) measured in mmHg</measure>
    <time_frame>10 weeks</time_frame>
    <description>mPAP will be measured at rest and during exercise and is a measure of pulmonary vascular pressure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary vascular resistance (PVR) measured in dynes</measure>
    <time_frame>10 weeks</time_frame>
    <description>PVR will be measured at rest and during exercise and is a measure of pulmonary hemodynamic function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right ventricular contractile function measured as % fractional area change (RV FAC).</measure>
    <time_frame>10 weeks</time_frame>
    <description>RV FAC is a measure of overall contractile function of the right ventricle.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular contractile function measured as % fractional area change (LV FAC).</measure>
    <time_frame>10 weeks</time_frame>
    <description>LV FAC is a measure of overall contractile function of the left ventricle.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Slope of the relationship between mean pulmonary arterial pressure and cardiac output (mPAP-Q slope) measured in mmHg/L/min.</measure>
    <time_frame>10 weeks</time_frame>
    <description>The mPAP-Q slope during exercise is a measure of the pulmonary hemodynamic response to exercise. A slope &gt;3 is 'abnormal', and a steeper slope is related to poorer pulmonary hemodynamic function.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Heart Failure</condition>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>Exercise Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two sets of exercise testing (before and after) 10 weeks of supervised exercise training (3 sessions per week) at Mayo Clinic Florida.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Groups</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Two sets of exercise testing while continuing with standard medical care in between.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise Training</intervention_name>
    <description>10 weeks of supervised exercise training, 3 sessions per week at the cardiac rehab clinic at Mayo Clinic Florida.</description>
    <arm_group_label>Exercise Training</arm_group_label>
    <other_name>Cardiac Rehab</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  NYHA functional class I-IIIb.&#xD;
&#xD;
          -  LVEF &lt; 40%.&#xD;
&#xD;
          -  Clinically-stable for &gt; 3 months [no change in disease status or medication].&#xD;
&#xD;
          -  Willing and able to provide written informed consent and perform cycle-ergometer or&#xD;
             treadmill based exercise.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  NYHA class IV HF.&#xD;
&#xD;
          -  Diagnosis of diastolic HF.&#xD;
&#xD;
          -  Comorbidities such as obesity (BMI &gt;36), uncontrolled systemic hypertension, type 2&#xD;
             diabetes, and COPD (FEV1 &lt;50%).&#xD;
&#xD;
          -  Musculoskeletal or other conditions that would limit exercise participation.&#xD;
&#xD;
          -  Pregnant or nursing women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bryan J Taylor, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erika Douglass, MPH</last_name>
    <phone>(904) 953-6595</phone>
    <email>douglass.erika@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robyn Bryde, MD</last_name>
    <phone>(904) 953 -7274</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 26, 2021</study_first_submitted>
  <study_first_submitted_qc>May 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2021</study_first_posted>
  <last_update_submitted>May 26, 2021</last_update_submitted>
  <last_update_submitted_qc>May 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Bryan Taylor</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Exercise training</keyword>
  <keyword>Right ventricle</keyword>
  <keyword>Exercise capacity</keyword>
  <keyword>Quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

